Pharmacokinetics of Isorhynchophylline in Rat Plasma after Intravenous Administration

被引:0
作者
Ren, Ke [1 ]
Jin, Yue [2 ]
Wang, Xianqin [2 ]
Wei, Zhen [3 ]
机构
[1] Ningbo YinZhou 2 Hosp, Dept Pharm, Ningbo 315192, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pharm, Wenzhou 325000, Peoples R China
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2019年 / 38卷 / 05期
关键词
isorhynchophylline; pharmacokinetics; rat; UPLC-MS/MS; PERFORMANCE LIQUID-CHROMATOGRAPHY; UPLC-MS/MS; RHYNCHOPHYLLINE; METABOLITES; EPIMERS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Isorhynchophylline is the main tetracycline hydroxindole alkaloid in uncaria, which has similar pharmacological activity with uncaria. In this study, we used UPLC-MS/MS to detect isorhynchophylline in rat plasma, and investigated its pharmacokinetics in rats. Diazepam was utilized as an internal standard (IS), and acetonitrile precipitation method was used to process the plasma samples. Chromatographic separation was achieved using a UPLC BEH C18 column using mobile phase of acetonitrile:0.1 % formic acid with gradient elution. Electrospray ionization (ESI) tandem mass spectrometry in multiple reaction monitoring (MRM) mode with positive ionization was applied. The results indicated that within the range of 1-200 ng/mL, linearity of isorhynchophylline in rat plasma was acceptable (r > 0.995), and the lower limit of quantification (LLOQ) was 1 ng/mL. Intra-day and inter-day precision RSD of isorhynchophylline in rat plasma were lower than 15%. Accuracy range was between 88.1 and 106.1 %, recovery was higher than 81.8%, and matrix effect was between 95.0 and 97.1%. The method was successfully applied in the pharmacokinetics of isorhynchophylline in rats after intravenous administration. The main pharmacokinetic parameters t(1/2), CL, and V were 2.6 +/- 1.9 h, 8.2 +/- 4.4 L/h/kg, and 27.5 +/- 18.1 L/kg, respectively.
引用
收藏
页码:991 / 995
页数:5
相关论文
共 29 条
[1]  
[Anonymous], 2014, GUID IND AN PROC MET
[2]  
Bao SH, 2016, INT J CLIN EXP MED, V9, P6309
[3]  
Cao GQ, 2015, LAT AM J PHARM, V34, P45
[4]  
Chen DX, 2016, LAT AM J PHARM, V35, P2279
[5]  
Chen DX, 2015, LAT AM J PHARM, V34, P1913
[6]   Pharmacokinetics and Bioavailability Study of Tubeimoside I in ICR Mice by UPLC-MS/MS [J].
Chen, Lianguo ;
Weng, Qinghua ;
Li, Feifei ;
Liu, Jinlai ;
Zhang, Xueliang ;
Zhou, Yunfang .
JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY, 2018, 2018
[7]   Pharmacokinetic study of ardisiacrispin A in rat plasma after intravenous administration by UPLC-MS/MS [J].
Fang, Bingmu ;
Bao, Shihui ;
Wang, Shuanghu ;
Chen, Minle ;
Chen, Bingbao ;
Su, Ke ;
Wen, Congcong ;
Zhou, Yunfang ;
Wang, Xianqin ;
Jin, Yuepeng .
BIOMEDICAL CHROMATOGRAPHY, 2017, 31 (03)
[8]   Determination and Pharmacokinetic Study of Dauricine in Rat Plasma by UPLC-MS/MS [J].
Geng, Peiwu ;
Zhang, Jing ;
Chen, Bingbao ;
Wang, Qianqian ;
Wang, Shuanghu ;
Wen, Congcong .
ACTA CHROMATOGRAPHICA, 2018, 30 (02) :136-140
[9]   Determination of armepavine in mouse blood by UPLC-MS/MS and its application to pharmacokinetic study [J].
Geng, Peiwu ;
Luo, Jun ;
Weng, Ziwei ;
Fan, Zhehua ;
Zhang, Bin ;
Ma, Jianshe ;
Wang, Xianqin ;
Zhang, Meiling .
BIOMEDICAL CHROMATOGRAPHY, 2018, 32 (09)
[10]  
Huang Bin, 1998, Yaoxue Xuebao, V33, P48